1-[2,3-Bis(tetradecyloxy)propyl]-3-[2-(piperazin-1-yl)ethyl]urea

Santiago Grijalvo; Samuel Núñez; Ramon Eritja

doi:10.3390/M873

Molbank (Nov 2015)

1-[2,3-Bis(tetradecyloxy)propyl]-3-[2-(piperazin-1-yl)ethyl]urea

Santiago Grijalvo,
Samuel Núñez,
Ramon Eritja

Affiliations

Santiago Grijalvo: Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona E-08034, Spain
Samuel Núñez: Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona E-08034, Spain
Ramon Eritja: Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona E-08034, Spain

DOI: https://doi.org/10.3390/M873
Journal volume & issue: Vol. 2015, no. 4
p. M873

Abstract

Read online

Starting from 2,3-bis(tetradecyloxy)propan-1-amine (1), the synthesis of the target compound 1-[2,3-bis(tetradecyloxy)propyl]-3-[2-(piperazin-1-yl)ethyl]urea (2) is reported. The title compound was characterized by 1H-NMR, 13C-NMR and ESI/MS analysis.

Published in Molbank

ISSN: 1422-8599 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Science: Chemistry: Inorganic chemistry
Website: https://www.mdpi.com/journal/molbank

About the journal

Abstract

Keywords